Presentation TCT 2017 Point A Multi-Device Lesion-Specific Approach is Preferred! Presenter: Michael J. Reardon November 01, 2017
Presentation TCT 2017 The Compelling Saga of Stroke after TAVR: Key Messages From NeuroARC Presenter: Michael J. Reardon, Didier Tchetche, Alexandra J. Lansky October 31, 2017
Presentation TCT 2017 LOTUS TAVR Technology Review (Including EDGE) and Clinical Program Updates Presenter: Michael J. Reardon October 31, 2017
Presentation TCT 2017 Viewpoint #1: PARTNER 2A and SURTAVI are Convincing TAVR is Preferred in ALL (Appropriate) Intermediate-Risk Patients Presenter: Michael J. Reardon October 30, 2017
Presentation TVT 2017 Spotlight Lecture: The SURTAVI LBCT: CoreValve vs Surgery in Intermediate-Risk Aortic Stenosis Patients Presenter: David J. Cohen, Jeffrey J. Popma, Michael J. Reardon June 16, 2017
Presentation TVT 2017 The Portico TAVR System: A Cool Case, New Technology, and Clinical Program Updates Presenter: Martin B. Leon, Michael J. Reardon, Raj Makkar June 16, 2017
Presentation TVT 2017 The ACURATE TAVR System: A Cool Case, New Technology, and Clinical Program Updates Presenter: Martin B. Leon, Michael J. Reardon, Thomas Walther June 16, 2017
Presentation TVT 2017 The LOTUS TAVR System: A Cool Case, New Technology (Including EDGE), and Clinical Program Updates Presenter: Michael J. Reardon June 16, 2017
Presentation TVT 2017 The REPRISE III LBCT: A Randomized Trial Comparing LOTUS vs Self-Expanding CoreValve in High-Risk Aortic Stenosis Patients Presenter: Axel Linke, Jeffrey J. Popma, Michael J. Reardon June 15, 2017
Presentation SWVS 2017 Cases: The Good, The Bad and The Ugly Presenter: Michael J. Reardon May 07, 2017
Presentation SWVS 2017 Extreme Sizing: The Very Small and the Very Large Presenter: Michael J. Reardon May 06, 2017
Presentation SWVS 2017 TAVR: Evolving Risk Assessment and Expectations Presenter: Michael J. Reardon May 06, 2017
Presentation SWVS 2017 Heart Valve Dysfunction With ESRD: Options and Expectations Presenter: Michael J. Reardon May 06, 2017
Presentation ACC 2017 First Results from the SURTAVI Clinical Trial Presenter: Michael J. Reardon March 17, 2017
Presentation SIF 2017 Bicuspid Aortic Valve Disease and TAVR Presenter: Michael J. Reardon March 11, 2017